BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 9558113)

  • 1. Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.
    Proost P; Struyf S; Couvreur M; Lenaerts JP; Conings R; Menten P; Verhaert P; Wuyts A; Van Damme J
    J Immunol; 1998 Apr; 160(8):4034-41. PubMed ID: 9558113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1.
    Sozzani S; Zhou D; Locati M; Rieppi M; Proost P; Magazin M; Vita N; van Damme J; Mantovani A
    J Immunol; 1994 Apr; 152(7):3615-22. PubMed ID: 8144937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
    Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
    BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV.
    Van Coillie E; Proost P; Van Aelst I; Struyf S; Polfliet M; De Meester I; Harvey DJ; Van Damme J; Opdenakker G
    Biochemistry; 1998 Sep; 37(36):12672-80. PubMed ID: 9730840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines.
    Proost P; Van Leuven P; Wuyts A; Ebberink R; Opdenakker G; Van Damme J
    Cytokine; 1995 Feb; 7(2):97-104. PubMed ID: 7780043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis.
    Tsuneyama K; Harada K; Yasoshima M; Hiramatsu K; Mackay CR; Mackay IR; Gershwin ME; Nakanuma Y
    J Pathol; 2001 Jan; 193(1):102-9. PubMed ID: 11169522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and identification of naturally modified C-C chemokines MCP-1, MCP-2 and RANTES: effects of posttranslational modifications on receptor usage, chemotactic and anti-HIV-1 activity.
    Proost P; Struyf S; Wuyts A; Menten P; De Meester I; Lambeir AM; Scharpé S; Schols D; De Clercq E; Van Damme J
    Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):73-5. PubMed ID: 9831190
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody.
    Reid C; Rushe M; Jarpe M; van Vlijmen H; Dolinski B; Qian F; Cachero TG; Cuervo H; Yanachkova M; Nwankwo C; Wang X; Etienne N; Garber E; Bailly V; de Fougerolles A; Boriack-Sjodin PA
    Protein Eng Des Sel; 2006 Jul; 19(7):317-24. PubMed ID: 16682434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes.
    Uguccioni M; D'Apuzzo M; Loetscher M; Dewald B; Baggiolini M
    Eur J Immunol; 1995 Jan; 25(1):64-8. PubMed ID: 7531149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor.
    Franci C; Wong LM; Van Damme J; Proost P; Charo IF
    J Immunol; 1995 Jun; 154(12):6511-7. PubMed ID: 7759884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
    Wuyts A; D'Haese A; Cremers V; Menten P; Lenaerts JP; De Loof A; Heremans H; Proost P; Van Damme J
    J Immunol; 1999 Dec; 163(11):6155-63. PubMed ID: 10570306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor.
    Struyf S; Proost P; Sozzani S; Mantovani A; Wuyts A; De Clercq E; Schols D; Van Damme J
    J Immunol; 1998 Sep; 161(6):2672-5. PubMed ID: 9743322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3.
    Allavena P; Bianchi G; Zhou D; van Damme J; Jílek P; Sozzani S; Mantovani A
    Eur J Immunol; 1994 Dec; 24(12):3233-6. PubMed ID: 7805752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of a lymphocyte chemotactic factor produced by the murine thymic epithelial cell line MTEC1: identification as a 30 kDa glycosylated form of MCP-1.
    Liu ZG; Haelens A; Wuyts A; Struyf S; Pang XW; Proost P; Chen WF; van Damme J
    Eur Cytokine Netw; 1996 Sep; 7(3):381-8. PubMed ID: 8954181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulating properties of 5-oxo-eicosanoids for human monocytes: synergism with monocyte chemotactic protein-1 and -3.
    Sozzani S; Zhou D; Locati M; Bernasconi S; Luini W; Mantovani A; O'Flaherty JT
    J Immunol; 1996 Nov; 157(10):4664-71. PubMed ID: 8906847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression.
    Bonfield TL; John N; Malur A; Barna BP; Culver DA; Kavuru MS; Thomassen MJ
    Clin Immunol; 2005 Jan; 114(1):79-85. PubMed ID: 15596412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3.
    Weber M; Uguccioni M; Ochensberger B; Baggiolini M; Clark-Lewis I; Dahinden CA
    J Immunol; 1995 Apr; 154(8):4166-72. PubMed ID: 7535823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells.
    Marra F; Romanelli RG; Giannini C; Failli P; Pastacaldi S; Arrighi MC; Pinzani M; Laffi G; Montalto P; Gentilini P
    Hepatology; 1999 Jan; 29(1):140-8. PubMed ID: 9862860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
    Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes.
    Taub DD; Proost P; Murphy WJ; Anver M; Longo DL; van Damme J; Oppenheim JJ
    J Clin Invest; 1995 Mar; 95(3):1370-6. PubMed ID: 7883984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.